{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T19:52:18Z","timestamp":1768852338186,"version":"3.49.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003624","name":"Ministry of Agriculture, Food and Rural Affairs","doi-asserted-by":"publisher","award":["313014-3"],"award-info":[{"award-number":["313014-3"]}],"id":[{"id":"10.13039\/501100003624","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microb Cell Fact"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12934-017-0648-2","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T08:05:22Z","timestamp":1487750722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Artificially designed recombinant protein composed of multiple epitopes of foot-and-mouth disease virus as a vaccine candidate"],"prefix":"10.1186","volume":"16","author":[{"given":"Ho-Bin","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-Chuan","family":"Piao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Yeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Yun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Duck","family":"Bok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong-Su","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Kee","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Jaie","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,22]]},"reference":[{"key":"648_CR1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.prevetmed.2013.07.013","volume":"112","author":"TJD Knight-Jones","year":"2013","unstructured":"Knight-Jones TJD, Rushton J. The economic impacts of foot and mouth disease\u2014what are they, how big are they and where do they occur? Prev Vet Med. 2013;112:161\u201373.","journal-title":"Prev Vet Med"},{"key":"648_CR2","doi-asserted-by":"crossref","first-page":"5660","DOI":"10.1016\/j.vaccine.2006.10.052","volume":"25","author":"P Kitching","year":"2007","unstructured":"Kitching P, Hammond J, Jeggo M, Charleston B, Paton D, Rodriguez L, Heckert R. Global FMD control\u2014is it an option? Vaccine. 2007;25:5660\u20134.","journal-title":"Vaccine"},{"key":"648_CR3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0147-9571(02)00027-9","volume":"25","author":"E Domingo","year":"2002","unstructured":"Domingo E, Baranowski E, Escarm\u0131\u0301s C, Sobrino F. Foot-and-mouth disease virus. Comp Immunol Microbiol Infect Dis. 2002;25:297\u2013308.","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"648_CR4","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.vaccine.2014.12.007","volume":"33","author":"S-Y Lee","year":"2015","unstructured":"Lee S-Y, Park M-E, Kim R-H, Ko M-K, Lee K-N, Kim S-M, Shim H-S, Kim B, Lee J-S, Park J-H. Genetic and immunologic relationships between vaccine and field strains for vaccine selection of type A foot-and-mouth disease virus circulating in East Asia. Vaccine. 2015;33:664\u20139.","journal-title":"Vaccine"},{"key":"648_CR5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1099\/0022-1317-82-3-609","volume":"82","author":"AR Samuel","year":"2001","unstructured":"Samuel AR, Knowles NJ. Foot-and-mouth disease type O viruses exhibit genetically and geographically distinct evolutionary lineages (topotypes). J Gen Virol. 2001;82:609\u201321.","journal-title":"J Gen Virol"},{"key":"648_CR6","doi-asserted-by":"crossref","first-page":"D90","DOI":"10.1016\/j.vaccine.2009.08.039","volume":"27","author":"LL Rodriguez","year":"2009","unstructured":"Rodriguez LL, Grubman MJ. Foot and mouth disease virus vaccines. Vaccine. 2009;27:D90\u20134.","journal-title":"Vaccine"},{"key":"648_CR7","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nrd2224","volume":"6","author":"AW Purcell","year":"2007","unstructured":"Purcell AW, McCluskey J, Rossjohn J. More than one reason to rethink the use of peptides in vaccine design. Nat Rev Drug Discov. 2007;6:404\u201314.","journal-title":"Nat Rev Drug Discov"},{"key":"648_CR8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0168-1702(02)00261-7","volume":"91","author":"T Doel","year":"2003","unstructured":"Doel T. FMD vaccines. Virus Res. 2003;91:81\u201399.","journal-title":"Virus Res"},{"key":"648_CR9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-1-4757-9271-3_15","volume-title":"Genetic variability and antigenic diversity of foot-and-mouth disease virus. In: virus variability, epidemiology and control","author":"E Domingo","year":"1990","unstructured":"Domingo E, Mateu MG, Mart\u00ednez MA, Dopazo J, Moya A, Sobrino F. Genetic variability and antigenic diversity of foot-and-mouth disease virus. In: virus variability, epidemiology and control. Berlin: Springer; 1990. p. 233\u201366."},{"key":"648_CR10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/BA20000034","volume":"32","author":"M Hansson","year":"2000","unstructured":"Hansson M, Nygren PA. Design and production of recombinant subunit vaccines. Biotechnol Appl Biochem. 2000;32:95\u2013107.","journal-title":"Biotechnol Appl Biochem"},{"key":"648_CR11","unstructured":"Skowron P Z-SA, Zolnierkiewicz O, Skowron M, Janus L, Jezewska-Frackowiak J, Szymanska A. Sposob uzyskiwania bialka poliepitopowego oraz wektor DNA do realizacji tego sposobu. Urzad Patentowy RP 2014, no P.407950."},{"key":"648_CR12","unstructured":"Skowron P Z-SA, Zolnierkiewicz O, Skowron M, Janus L, Jezewska-Frackowiak J, Krefft D, Nidzworski D, Szemiako K, Maciejewska N, Nowak M, Szymanska A. A method of obtaining a polyepitopic protein as well as a DNA vector for embodying this method. World Intellectual Property Organization. 2015. WO 2015162560 A1."},{"key":"648_CR13","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3923\/ajava.2012.1261.1265","volume":"7","author":"H Tang","year":"2012","unstructured":"Tang H, Liu XS, Fang YZ, Pan L, Zhang ZW, Zhou P, Lv JL, Jiang ST, Hu WF, Zhang P. The epitopes of foot and mouth disease. Asian J Anim Vet Adv. 2012;7:1261\u20135.","journal-title":"Asian J Anim Vet Adv"},{"key":"648_CR14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.vetmic.2007.05.033","volume":"125","author":"J-L Wang","year":"2007","unstructured":"Wang J-L, Liu M-Q, Han J, Chen W-Z, Cong W, Cheng G, Gao Y-H, Lu Y-G, Chen J-L, Zuo X-P. A peptide of foot-and-mouth disease virus serotype Asia1 generating a neutralizing antibody response, and an immunostimulatory peptide. Vet Microbiol. 2007;125:224\u201331.","journal-title":"Vet Microbiol"},{"key":"648_CR15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/0022-1317-70-1-59","volume":"70","author":"C Bolwell","year":"1989","unstructured":"Bolwell C, Clarke B, Parry N, Ouldridge E, Brown F, Rowlands D. Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies. J Gen Virol. 1989;70:59\u201368.","journal-title":"J Gen Virol"},{"key":"648_CR16","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/j.1460-2075.1995.tb07158.x","volume":"14","author":"N Verdaguer","year":"1995","unstructured":"Verdaguer N, Mateu M, Andreu D, Giralt E, Domingo E, Fita I. Structure of the major antigenic loop of foot-and-mouth disease virus complexed with a neutralizing antibody: direct involvement of the Arg-Gly-Asp motif in the interaction. The EMBO J. 1995;14:1690.","journal-title":"The EMBO J"},{"key":"648_CR17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/298030a0","volume":"298","author":"JL Bittle","year":"1982","unstructured":"Bittle JL, Houghten RA, Alexander H, Shinnick TM, Sutcliffe JG, Lerner RA. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature. 1982;298:30\u20133.","journal-title":"Nature"},{"key":"648_CR18","doi-asserted-by":"publisher","unstructured":"Blanco E, Cubillos C, Moreno N, B\u00e1rcena J, de la Torre BG, Andreu D, Sobrino F. B epitope multiplicity and B\/T epitope orientation influence immunogenicity of foot-and-mouth disease peptide vaccines. Clin Dev Immunol. 2013;2013:475960. doi: 10.1155\/2013\/475960 .","DOI":"10.1155\/2013\/475960"},{"key":"648_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2859-4-1","volume":"4","author":"HP S\u00f8rensen","year":"2005","unstructured":"S\u00f8rensen HP, Mortensen KK. Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli. Microb Cell Fact. 2005;4:1.","journal-title":"Microb Cell Fact"},{"key":"648_CR20","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1110\/ps.8.8.1668","volume":"8","author":"RB Kapust","year":"1999","unstructured":"Kapust RB, Waugh DS. Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused. Protein Sci. 1999;8:1668\u201374.","journal-title":"Protein Sci"},{"key":"648_CR21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00284-009-9455-2","volume":"59","author":"EB Kim","year":"2009","unstructured":"Kim EB, Piao DC, Son JS, Choi YJ. Cloning and characterization of a novel tuf promoter from Lactococcus lactis subsp. lactis IL1403. Curr Microbiol. 2009;59:425\u201331.","journal-title":"Curr Microbiol"},{"key":"648_CR22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0003-2697(89)90602-7","volume":"182","author":"SC Gill","year":"1989","unstructured":"Gill SC, Von Hippel PH. Calculation of protein extinction coefficients from amino acid sequence data. Anal Biochem. 1989;182:319\u201326.","journal-title":"Anal Biochem"},{"key":"648_CR23","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/ng.904","volume":"43","author":"J Zhang","year":"2011","unstructured":"Zhang J, Zahir N, Jiang Q, Miliotis H, Heyraud S, Meng X, Dong B, Xie G, Qiu F, Hao Z. The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp\/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness. Nat Genet. 2011;43:902\u20137.","journal-title":"Nat Genet"},{"key":"648_CR24","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10295-013-1273-7","volume":"40","author":"J-G Jung","year":"2013","unstructured":"Jung J-G, Lee YJ, Velmurugan N, Ko Y-J, Lee H-S, Jeong KJ. High-yield production of the VP1 structural protein epitope from serotype O foot-and-mouth disease virus in Escherichia coli. J Ind Microbiol Biotechnol. 2013;40:705\u201313.","journal-title":"J Ind Microbiol Biotechnol"},{"key":"648_CR25","first-page":"1","volume":"3","author":"GR Grimsley","year":"2004","unstructured":"Grimsley GR, Pace CN. Spectrophotometric determination of protein concentration. Curr Protocols Protein Sci. 2004;3:1\u20133.","journal-title":"Curr Protocols Protein Sci."},{"key":"648_CR26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00253-004-1814-0","volume":"67","author":"S Jana","year":"2005","unstructured":"Jana S, Deb J. RETRACTED ARTICLE: strategies for efficient production of heterologous proteins in Escherichia coli. Appl Microbiol Biotechnol. 2005;67:289\u201398.","journal-title":"Appl Microbiol Biotechnol"},{"key":"648_CR27","doi-asserted-by":"crossref","first-page":"R177","DOI":"10.1016\/S0969-2126(00)00193-3","volume":"8","author":"RC Stevens","year":"2000","unstructured":"Stevens RC. Design of high-throughput methods of protein production for structural biology. Structure.\u00a02000;8:R177\u201385.","journal-title":"Structure"},{"key":"648_CR28","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.intimp.2015.08.017","volume":"28","author":"M Fang","year":"2015","unstructured":"Fang M, Wang H, Tang T, Zhao P, Du J, Guo S, Wei H, Xu H, Wan M, Wei X. Single immunization with a recombinant multiple-epitope protein induced protection against FMDV type Asia 1 in cattle. Int Immunopharmacol. 2015;28:960\u20136.","journal-title":"Int Immunopharmacol"},{"key":"648_CR29","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.vetmic.2013.11.023","volume":"168","author":"Y Cao","year":"2014","unstructured":"Cao Y, Lu Z, Li D, Fan P, Sun P, Bao H, Fu Y, Li P, Bai X, Chen Y. Evaluation of cross-protection against three topotypes of serotype O foot-and-mouth disease virus in pigs vaccinated with multi-epitope protein vaccine incorporated with poly (I: C). Vet Microbiol. 2014;168:294\u2013301.","journal-title":"Vet Microbiol"},{"key":"648_CR30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1128\/CVI.00236-10","volume":"18","author":"J-J Shao","year":"2011","unstructured":"Shao J-J, Wong CK, Lin T, Lee SK, Cong G-Z, Sin FWY, Du J-Z, Gao S-D, Liu X-T, Cai X-P. Promising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type O in swine. Clin Vaccine Immunol. 2011;18:143\u20139.","journal-title":"Clin Vaccine Immunol"},{"key":"648_CR31","doi-asserted-by":"crossref","first-page":"9798","DOI":"10.1128\/JVI.00577-06","volume":"80","author":"A Burman","year":"2006","unstructured":"Burman A, Clark S, Abrescia NG, Fry EE, Stuart DI, Jackson T. Specificity of the VP1 GH loop of foot-and-mouth disease virus for \u03b1v integrins. J Virol. 2006;80:9798\u2013810.","journal-title":"J Virol"},{"key":"648_CR32","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/viro.2001.1096","volume":"288","author":"E Baranowski","year":"2001","unstructured":"Baranowski E, Ruiz-Jarabo CM, Lim F, Domingo E. Foot-and-mouth disease virus lacking the VP1 GH loop: the mutant spectrum uncovers interactions among antigenic sites for fitness gain. Virology. 2001;288:192\u2013202.","journal-title":"Virology"},{"key":"648_CR33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.colsurfb.2006.11.043","volume":"55","author":"D-M He","year":"2007","unstructured":"He D-M, Qian K-X, Shen G-F, Li Y-N, Zhang Z-F, Su Z-L, Shao H-B. Stable expression of foot-and-mouth disease virus protein VP1 fused with cholera toxin B subunit in the potato (Solanum tuberosum). Colloids Surf B. 2007;55:159\u201363.","journal-title":"Colloids Surf B"},{"key":"648_CR34","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1016\/S0264-410X(03)00363-3","volume":"21","author":"J-H Wang","year":"2003","unstructured":"Wang J-H, Liang C-M, Peng J-M, Shieh J-J, Jong M-H, Lin Y-L, Sieber M, Liang S-M. Induction of immunity in swine by purified recombinant VP1 of foot-and-mouth disease virus. Vaccine. 2003;21:3721\u20139.","journal-title":"Vaccine"},{"key":"648_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2859-4-27","volume":"4","author":"E Garc\u00eda-Fruit\u00f3s","year":"2005","unstructured":"Garc\u00eda-Fruit\u00f3s E, Gonz\u00e1lez-Montalb\u00e1n N, Morell M, Vera A, Ferraz RM, Ar\u00eds A, Ventura S, Villaverde A. Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins. Microb Cell Fact. 2005;4:1.","journal-title":"Microb Cell Fact"},{"key":"648_CR36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1475-2859-3-11","volume":"3","author":"LF Vallejo","year":"2004","unstructured":"Vallejo LF, Rinas U. Strategies for the recovery of active proteins through refolding of bacterial inclusion body proteins. Microb Cell Fact. 2004;3:11.","journal-title":"Microb Cell Fact"},{"key":"648_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pep.2016.01.015","volume":"122","author":"Y Chen","year":"2016","unstructured":"Chen Y, Wang Q, Zhang C, Li X, Gao Q, Dong C, Liu Y, Su Z. Improving the refolding efficiency for proinsulin aspart inclusion body with optimized buffer compositions. Protein Expr Purif. 2016;122:1\u20137.","journal-title":"Protein Expr Purif"},{"key":"648_CR38","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jviromet.2012.03.036","volume":"185","author":"Y Cao","year":"2012","unstructured":"Cao Y, Lu Z, Li P, Sun P, Fu Y, Bai X, Bao H, Chen Y, Li D, Liu Z. Improved neutralising antibody response against foot-and-mouth-disease virus in mice inoculated with a multi-epitope peptide vaccine using polyinosinic and poly-cytidylic acid as an adjuvant. J Virol Methods. 2012;185:124\u20138.","journal-title":"J Virol Methods"},{"key":"648_CR39","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1073\/pnas.0930122100","volume":"100","author":"BJ Bennion","year":"2003","unstructured":"Bennion BJ, Daggett V. The molecular basis for the chemical denaturation of proteins by urea. Proc Natl Acad Sci. 2003;100:5142\u20137.","journal-title":"Proc Natl Acad Sci"},{"key":"648_CR40","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(02)00620-7","volume":"108","author":"AR Fersht","year":"2002","unstructured":"Fersht AR, Daggett V. Protein folding and unfolding at atomic resolution. Cell. 2002;108:573\u201382.","journal-title":"Cell"},{"key":"648_CR41","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1016\/j.vaccine.2010.02.074","volume":"28","author":"V Fowler","year":"2010","unstructured":"Fowler V, Knowles N, Paton D, Barnett P. Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 GH loop deletion. Vaccine. 2010;28:3428\u201334.","journal-title":"Vaccine"},{"key":"648_CR42","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/PL00012487","volume":"59","author":"D Dougan","year":"2002","unstructured":"Dougan D, Mogk A, Bukau B. Protein folding and degradation in bacteria: to degrade or not to degrade? That is the question. Cell Mol Life Sci. 2002;59:1607\u201316.","journal-title":"Cell Mol Life Sci"},{"key":"648_CR43","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nature02263","volume":"426","author":"AL Goldberg","year":"2003","unstructured":"Goldberg AL. Protein degradation and protection against misfolded or damaged proteins. Nature. 2003;426:895\u20139.","journal-title":"Nature"},{"key":"648_CR44","doi-asserted-by":"crossref","first-page":"12703","DOI":"10.12703\/P5-40","volume":"5","author":"TA Packard","year":"2013","unstructured":"Packard TA, Cambier JC. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation. F1000Prime Rep. 2013;5:12703.","journal-title":"F1000Prime Rep."},{"key":"648_CR45","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1089\/aid.1994.10.371","volume":"10","author":"YH Abacioglu","year":"1994","unstructured":"Abacioglu YH, Fouts TR, Laman JD, Claassen E, Pincus SH, Moore JP, Roby CA, Kamin-Lewis R, Lewis GK. Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies. AIDS Res Hum Retroviruses. 1994;10:371\u201381.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"648_CR46","first-page":"e933","volume":"1","author":"R Taherkhani","year":"2015","unstructured":"Taherkhani R, Farshadpour F. A new strategy for development of hepatitis E vaccine: epitope-based vaccines. Pathog Infect Dis. 2015;1:e933.","journal-title":"Pathog Infect Dis."},{"key":"648_CR47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.abb.2007.08.034","volume":"469","author":"E Kloss","year":"2008","unstructured":"Kloss E, Courtemanche N, Barrick D. Repeat-protein folding: new insights into origins of cooperativity, stability, and topology. Arch Biochem Biophys. 2008;469:83\u201399.","journal-title":"Arch Biochem Biophys"}],"container-title":["Microbial Cell Factories"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12934-017-0648-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T19:54:47Z","timestamp":1568836487000},"score":1,"resource":{"primary":{"URL":"http:\/\/microbialcellfactories.biomedcentral.com\/articles\/10.1186\/s12934-017-0648-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,22]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["648"],"URL":"https:\/\/doi.org\/10.1186\/s12934-017-0648-2","relation":{},"ISSN":["1475-2859"],"issn-type":[{"value":"1475-2859","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,22]]},"article-number":"33"}}